NCT00453167View on ClinicalTrials.gov

Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

March 31, 2010

Conditions
Lung Cancer
Interventions
DRUG

Paclitaxel

Paclitaxel 80mg/m2 iv on day 1 and 8, every 3 weeks until disease progression

DRUG

Gemcitabine

Gemcitabine 1000mg/m2 iv on day 1 and 8, every 3 weeks until disease progression

Trial Locations (1)

411-769

National Cancer Center, Korea, Goyang-si

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV

NCT00453167 - Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter